BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.38

Reuters
09 May
BRIEF-ANI Pharmaceuticals Q1 Adjusted EPS USD 1.7 Vs. IBES Estimate USD 1.38

May 09 (Reuters) - ANI Pharmaceuticals Q1 revenue USD 68.959 million vs. IBES estimate USD 180.7 million.

  • Q1 net income USD 15.3 million
  • outlook FY adjusted EBITDA USD 195-205 million
  • outlook FY adjusted EPS USD 6.27-6.62

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10